Akbank T.A.S. (OTCMKTS:AKBTY – Get Free Report) was the recipient of a significant decline in short interest in the month of November. As of November 15th, there was short interest totalling 100 shares, a decline of 99.0% from the October 31st total of 10,400 shares. Based on an average daily trading volume, of 50,900 shares, the short-interest ratio is presently 0.0 days.
Akbank T.A.S. Price Performance
Akbank T.A.S. stock remained flat at $3.42 during mid-day trading on Wednesday. 48,462 shares of the company’s stock were exchanged, compared to its average volume of 27,602. The company has a current ratio of 0.32, a quick ratio of 0.32 and a debt-to-equity ratio of 0.73. Akbank T.A.S. has a fifty-two week low of $2.21 and a fifty-two week high of $4.46. The stock’s 50-day moving average price is $3.18 and its 200 day moving average price is $3.57.
Akbank T.A.S. (OTCMKTS:AKBTY – Get Free Report) last posted its quarterly earnings data on Thursday, October 24th. The company reported $0.10 earnings per share for the quarter. The firm had revenue of $1.18 billion for the quarter.
Akbank T.A.S. Company Profile
Akbank T.A.S., together with its subsidiaries, provides various banking products and services in Turkey and internationally. It operates through Consumer Banking and Private Banking; Commercial Banking, Corporate Banking, and SME Banking; and Treasury, Other, and Unallovated segments. The company’s consumer banking services comprise deposit accounts, retail loans, commercial installment loans, credit cards, insurance products, and asset management services, as well as bank cards, investment funds trading, automatic payment, foreign currency trading, safe deposit box rental, cheques, money transfer, investment banking, and telephone and internet banking.
Further Reading
- Five stocks we like better than Akbank T.A.S.
- What is a Secondary Public Offering? What Investors Need to Know
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Do S&P 500 Stocks Tell Investors About the Market?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Akbank T.A.S. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akbank T.A.S. and related companies with MarketBeat.com's FREE daily email newsletter.